Training Workshop: 2012 Web:

Slides:



Advertisements
Similar presentations
Future directions for CHAs Benchmarking Member Service.
Advertisements

CDI Module 10: A Review of Effective Skills Training
Mystery client survey on malaria rapid diagnostic tests Measuring service quality of private outlets.
Treatments of Risks and Uncertainty in Projects The availability of partial or imperfect information about a problem leads to two new category of decision-making.
Routine data systems related to case management Mac Otten Surveillance, Monitoring, and Evaluation Global Malaria Programme, WHO.
Discussion: Scaling up Diagnostic Testing Lawrence Barat, MD, MPH Senior Malaria Advisor USAID/PMI.
Chapter 9 Organizing and Using Data. Using Data behavior therapy uses data to plan and evaluate the effectiveness of interventions current data on antecedents,
Standard Curve Analysis for DNA Quantitation
4. FREQUENCY DISTRIBUTION
Country Data workshop: Building better dissemination systems for national development indicator Discrepancy analysis Lao PDR Presented by Vilaysook Sisoulath.
By Victor Chalwe, MD, MSC. ICIUM, Turkey.  The home management of malaria strategy is a WHO tool that identifies high risks groups such as children and.
Malaria in Zambia A refresher Scope of Presentation  Background on Malaria  Overview of malaria in Zambia  Interventions  Impact  Active Case.
SPSS Session 1: Levels of Measurement and Frequency Distributions
1 Price elasticity of demand and revenue implications Often in economics we look at how the value of one variable changes when another variable changes.
World Health Organization
World Health Organization
Moving forward in the diagnosis of infectious diseases in developing countries: a focus on malaria Forum organized by Fondation Mérieux & the Roll Back.
Translating Research into Policy: Rapid Diagnostic Tests (RDTs) for Malaria in Uganda Helen Counihan Malaria Consortium June 2007.
Treatment protocol. Who will be treated? People will be treated based only on the results of diagnostic tests performed, not on any other clinical assessment.
Statistical Analysis. Purpose of Statistical Analysis Determines whether the results found in an experiment are meaningful. Answers the question: –Does.
Chapter 17 Nursing Diagnosis
1 Understanding and Using NAMCS and NHAMCS Data: A Hands-On Workshop Susan M. Schappert Donald K. Cherry.
HAWKES LEARNING SYSTEMS Students Matter. Success Counts. Copyright © 2013 by Hawkes Learning Systems/Quant Systems, Inc. All rights reserved. Section 8.1.
Data Presentation.
Sub module 4 Drug Dispensing and Stock Management.
Training Workshop: 2012 Web:
Chemistry: Chapter 2 Fall SI Units  For a measurement to make sense, it requires both a number and a unit.  Many of the units you are familiar.
Copyright © 2010, 2007, 2004 Pearson Education, Inc. Section 9-2 Inferences About Two Proportions.
Training Workshop: 2012 Web:
Training Workshop: 2012 Web:
Chapter 12 The Analysis of Categorical Data and Goodness-of-Fit Tests.
1 © 2008 Brooks/Cole, a division of Thomson Learning, Inc. Chapter 12 The Analysis of Categorical Data and Goodness-of-Fit Tests.
IMPACT OF AN ESSENTIAL DRUGS LIST AND TREATMENT GUIDELINES ON PRESCRIBING IN SOUTH AFRICA In 1998 the National Department of Health (NDOH) published standard.
Current National Drug Policies in Lao P.D.R. By Dr Samlane Phompida Centre of Malariology, Parasitology & Entomology.
Issues in malaria diagnosis and treatment May 31, 2007 Jacek Skarbinski, MD Malaria Branch Centers for Disease Control and Prevention.
Chapter 7 Sampling Distributions Statistics for Business (Env) 1.
Determinants of Rational Use of Medicines Dr A K Sharma Prof & Head Dept of Pharmacology AFMC, Pune.
Two-way tables BPS chapter 6 © 2006 W. H. Freeman and Company.
Epidemiology of Tuberculosis in Correctional Facilities, United States, Surveillance, Epidemiology and Outbreak Investigations Branch Division.
Unit 4: Reporting, Data Management and Analysis #4-4-1.
Biostatistics in Practice Peter D. Christenson Biostatistician Session 3: Testing Hypotheses.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia & Dr. Michael Lynch Epidemiologist.
Indicators in Malaria Program Phases By Bayo S Fatunmbi [Technical Officer, Monitoring & Evaluation] ERAR-GMS, WHO Cambodia.
RAVREDA – AMI USAID Project report, Colombia 2009 SUPPLY CHAIN MANAGEMENT OF MALARIA MEDICINES & SUPPLIES, Supervision Tool pilot test experience in GUYANA.
Quantification from a TB Perspective PSM Workshop to Develop GFATM PSM plans for HIV, TB and Malaria February 2006, Nairobi.
Integrated Management of Childhood Illnesses
Lecture PowerPoint Slides Basic Practice of Statistics 7 th Edition.
Sampling Design and Analysis MTH 494 Lecture-21 Ossam Chohan Assistant Professor CIIT Abbottabad.
SAT’s week at St Peter’s In 2014/15 a new national curriculum framework was introduced by the government for Years 1, 3, 4 and 5 However, Years.
KS2 SATs Presentation to parents 20 th April 2016.
TAG Villanova Technical Analysis Group. VOLUME Understanding Volume  Volume is the number of shares or contracts over a given period of time, that is.
Elementary Statistics
Chapter 10: Comparing Two Populations or Groups
Elementary Statistics
Chapter 8: Inference for Proportions
Chapter 10: Comparing Two Populations or Groups
Impact of an essential drugs list and treatment guidelines on prescribing in South Africa.
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Chapter 10: Comparing Two Populations or Groups
Presentation transcript:

Training Workshop: 2012 Web:

Dashboard Summary Summary of data collected from OPD, Gives a summary of a health facilities malaria disease burden Illustrates the number of clinically and parasitologically confirmed cases i.e. RDT or microscopy (where available)at health facility level Presents a malaria drug situation at health facility.

Graph Number 1 Shows actual numbers of clinical, RDT positive and slide positive cases if reported. If clinical cases are reported, NMCC encourages a transition from clinically diagnosed and reported malaria cases to parasitologically confirmed cases i.e. either with RDTs or slide microscopy if microscopy available. The facility displayed here is reporting no clinical cases and no slide positive cases, only RDT positive cases.

Graph Number 2 Presents actual total outpatient attendance by week and the number of suspected malaria cases. Total outpatient attendance is collected to understand the broader trends in the facilities attendance patterns that might not be revealed by only reviewing the malaria data. Suspected malaria cases are a calculated number and are based on adding the number of clinical malaria cases and the number of cases tested for malaria

Graph number 3 Presents malaria positivity rates by week for RDT and slide microscopy. Malaria positivity is an important indicator of the level of true malaria presenting to the clinic. It is defined as the number of parasitologically confirmed malaria cases divided by the number of patients tested for malaria, presented separately for RDT and microscopy.

Graph number 4 Presents the number of suspected malaria cases tested, or the malaria testing rate. Parasitological confirmation of suspected cases is critical for understanding the true burden of malaria at facilities. Ensuring that those suspected of having malaria are tested is measured through the testing rate. It is calculated by the number of patients tested divided by the number of suspected cases. The desired testing rate should be 100%, meaning that sufficient diagnostic supplies are available and all patients suspected of having malaria are tested. This example facility is reporting that all of the suspected malaria patients are being tested.

Graph Number 5 Presents information on the number of ACT (Coartem) treatments dispensed by the facility by week in relation to the number of suspected malaria cases and the number treatable malaria cases. A treatable malaria case is defined as the number of clinical malaria cases plus the number of parasitologically confirmed positive malaria cases. There should be a consistent trend in the number of treatable malaria cases and the ACTs dispensed. In this example facility, the trend in these two indicators is identical and the trend lines overlap.

Graph Number 6 Presents the number of treatable cases, the number treatment doses of Coartem dispensed by pack size by week for the facility. This complements Figure 5 by introducing the relative pack size for Coartem dispensed.

Stock Table: Cumulative dispensed, balance, requirements, stockouts Table below summarizes both availability and stockouts of RDTs as well as ACTs (Coartem) by pack size. Table requires the number of previous weeks included to be specified. In the example provided, the number of previous weeks is 10. For the previous 10 week period, the numbers of RDT and Coartem by pack size is presented. The minimum amount required reflects the total number of treatable malaria cases reported by the facility for the previous 10 week period suggesting that, at a minimum, this amount of RDTs and Coartem treatment doses were required by the facility to meet this need. Stockouts for RDTs and Coartem by pack size presents whether the facility reported having no supplies for any week during the 10 week period considered and the number of weeks this outage was reported. This example facility had no reported stockouts of RDTs or Coartem by pack size for the previous 10 week period.

Coartem dispensed by pack size and confirmed cases by age Figure below presents percentage of ACTs (Coartem or ART-LUM) dispensed by pack size and parasitologically confirmed positive cases. It is dependent on the information supplied in stocks table for the number of previous weeks included in the presentation of results. Since the pack size of Coartem is determined by a patient’s weight, which is corresponds with patient age, the percentage of parasitologically confirmed positive malaria patients by age should reflect similar percentages as the volume of Coartem dispensed by pack size. While not an exact representation, these two figures together help determine if a facility is combining excessive smaller pack sizes for treatment of adults or if the facility may be cutting packs to accommodate treatments for young children. NMCC promotes having adequate supplies of the correct pack size and administering the appropriate pack size by weight is important to promote patient compliance to the full treatment course.